Limited Liability Company (LLC)
Diagnostica BANK Komórek Macierzystych
Diagnostica BANK Komórek Macierzystych Spółka z Ograniczoną Odpowiedzialnością
Diagnostica BANK Komórek Macierzystych Spółka z Ograniczoną Odpowiedzialnością (KRS 0000488713, NIP 9451993048) is a Polish company, headquartered in Kraków, Małopolskie voivodeship. Diagnostica BANK Komórek Macierzystych operates in: Human health activities (PKD 86.99.D). Industry: Healthcare. The company has been listed in the National Court Register since December 2, 2013. Diagnostica BANK Komórek Macierzystych's most recently reported net revenue was 3.3 M PLN for 2025.
No arrears identified in the analysed sources
No arrears or bankruptcy proceedings identified in the analysed sources.
Other activities
Credibility rating
80.2 / 100
Very good credibility
Insolvency risk
Very low
Low threat
Closure risk
1
/ 100
Risk comparison - scale 0 (safe) → 100 (critical)
No instability signals - ownership, management, PKD codes and company name remain relatively stable.
Shareholder changes
4
4/13 yrs
Board changes
7
7/13 yrs
PKD changes
3
3/13 yrs
Name changes
1
1/13 yrs
Data from 13 years of registry activity.
Payment reliability score from 2018–2025
Current: B (80/100)
Trend: stable (-0.3 pts/year)
High payment credibility - the company's financial condition is good and the risk of cooperating with it is low.
Standard limit from 2018–2025
Current: 1.2 M PLN
Safe: 710.8 K PLN
Difference between risk models
Closure - probability of ceasing operations (operational continuity). Insolvency - probability of formal bankruptcy / restructuring. The models use different data - results can diverge significantly when balance-sheet data is incomplete.
Founded
December 2, 2013
12 years in operation
Legal form
Limited Liability Company (LLC)
Registry: RejP
Headquarters
KRAKÓW
MAŁOPOLSKIE
Primary PKD
86.99.D
Human health activities
Share capital
392.0 K PLN
3,920 shares total
Shareholders
1
shareholder
Board
2 people
Sup. board: 3
Filed years
5 years
2018–2025
Registry entries
47
latest: July 13, 2026
Revenue
3.3 M PLN
2025
Net profit
1.4 M PLN
2025
Assets
8.2 M PLN
2025
Equity
2.4 M PLN
2025
EBITDA
1.3 M PLN
2025
Valuation
9.9 M PLN
High confidence
People holding roles at Diagnostica BANK Komórek Macierzystych according to the Polish National Court Register. Follow a name for that person's full profile and their other companies.
Rate business credibility - Diagnostica BANK Komórek Macierzystych.
No ratings
Competing companies or those operating in the same market segment as Diagnostica BANK Komórek Macierzystych (industry: Healthcare).
TUPADŁY· Healthcare
Revenue 2024: 6.0 M PLN
OTWOCK· Healthcare
Revenue 2025: 5.3 M PLN
KĘTY· Healthcare
Revenue 2024: 3.7 M PLN
STRZELIN· Healthcare
Revenue 2024: 3.3 M PLN
MODLNICA· Healthcare
Revenue 2024: 3.1 M PLN
KIELCE· Healthcare
Revenue 2024: 3.1 M PLN
Latest reporting year
2025
Available years
13
Filing entries
0
20 historical registry entries for Diagnostica BANK Komórek Macierzystych
Filing documents submitted (3 documents)
Board change
KR.XI NS-REJ.KRS/28514/25/29
Articles of association amended, Primary PKD code change, Secondary PKD code change
KR.XI NS-REJ.KRS/38116/25/434
Board change
KR.XI NS-REJ.KRS/12789/26/53
Filing documents submitted (3 documents)
Limited Liability Company (LLC)
Diagnostica BANK Komórek Macierzystych Spółka z Ograniczoną Odpowiedzialnością
Answers to questions about the company's activity, registered office, identifiers, financial data, capital and control.
Diagnostica BANK Komórek Macierzystych has 1 shareholder.
Yes - Diagnostica BANK Komórek Macierzystych's majority owner is POLSKI BANK KOMÓREK MACIERZYSTYCH SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ.
Diagnostica BANK Komórek Macierzystych's board has 2 members.